Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | FDPS | P14324 | 1/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3211688 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL7992010 | 1.00 | ALDH1A1 (0.56) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL246323 | 0.94 | ALDH1A1 (0.61) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL8371513 | 0.91 | ALDH1A1 (0.59) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL1524953 | 0.89 | ALDH1A1 (0.52) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL3683901 | 0.86 | ALDH1A1 (0.60) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL27029040 | 0.86 | ALDH1A1 (0.60) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL9484385 | 0.86 | ALDH1A1 (0.60) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 | |
| SCHEMBL10069015 | 0.85 | APP (0.58) | ALDH1A1MAPTHPGDKDM4ERECQL | |
| SCHEMBL3720061 | 0.85 | ALDH1A1 (0.69) | ALDH1A1MAPTHPGDLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7683041-B2 | Microgel particles for the delivery of bioactive materials | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-03-23 | — | — | US | disclosed |
| US-20060223776-A1 | Microgel particles for the delivery of bioactive materials | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-10-05 | — | — | US | disclosed |
| US-7056901-B2 | Microgel particles for the delivery of bioactive materials | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-06-06 | — | — | US | disclosed |
| EP-1490083-A1 | MICROGEL PARTICLES FOR THE DELIVERY OF BIOACTIVE MATERIALS | The Regents of the University of California (US) | 2004-12-29 | — | — | EP | disclosed |
| US-6770267-B2 | Methods of treating periodontal disease | SMITHKLINE BEECHAM CORPORATION | 2004-08-03 | — | — | US | disclosed |
| US-20040034020-A1 | Methods of treating periodontal disease | DALUGE SUSAN MARY (US) | 2004-02-19 | — | — | US | disclosed |
| EP-1104422-B1 | PHENYL XANTHINE DERIVATIVES | GLAXO GROUP LTD (GB) | 2004-02-18 | — | — | EP | disclosed |
| US-20030211158-A1 | Microgel particles for the delivery of bioactive materials | UNITED STATES DEPARTMENT OF ENERGY | 2003-11-13 | — | — | US | disclosed |
| WO-2003082316-A1 | MICROGEL PARTICLES FOR THE DELIVERY OF BIOACTIVE MATERIALS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-10-09 | — | — | WO | disclosed |
| US-6608069-B1 | Treating AIDS-related diarrhea or infectious diarrhea, tissue damage or dermatitis associated with leukocyte infiltration into tissue, asthma, inflammatory bowel condition, eczema, or psoriasis | SMITHKLINE BEECHAM CORPORATION | 2003-08-19 | — | — | US | disclosed |
| US-20030032804-A1 | Methods of treating periodontal disease | SMITHKLINE BEECHAM CORPORATION | 2003-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040034020-A1 | Methods of treating periodontal disease | MMP8, LPO, PTGES3 | ALDH1A1 2314/4885MAPT 3964/4885HPGD 41/4885 |
| US-20030211158-A1 | Microgel particles for the delivery of bioactive materials | CTSE, CHMP4B, GAA | ALDH1A1 2991/4885MAPT 1854/4885HPGD 1372/4885 |
| US-20030032804-A1 | Methods of treating periodontal disease | HPGDS, SELP, ALPI | ALDH1A1 2569/4885MAPT 3804/4885HPGD 32/4885 |
| US-20060223776-A1 | Microgel particles for the delivery of bioactive materials | CTSE, CHMP4B, GAA | ALDH1A1 2991/4885MAPT 1854/4885HPGD 1372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.